SE9902155L - Serum antibodies - Google Patents

Serum antibodies

Info

Publication number
SE9902155L
SE9902155L SE9902155A SE9902155A SE9902155L SE 9902155 L SE9902155 L SE 9902155L SE 9902155 A SE9902155 A SE 9902155A SE 9902155 A SE9902155 A SE 9902155A SE 9902155 L SE9902155 L SE 9902155L
Authority
SE
Sweden
Prior art keywords
antibody
well
nucleus pulposus
pulposus cells
antibodies
Prior art date
Application number
SE9902155A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE9902155D0 (en
Inventor
Bjoern Rydevik
Kjell Olmarker
Original Assignee
Bjoern Rydevik
Kjell Olmarker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bjoern Rydevik, Kjell Olmarker filed Critical Bjoern Rydevik
Priority to SE9902155A priority Critical patent/SE9902155L/en
Publication of SE9902155D0 publication Critical patent/SE9902155D0/en
Priority to PCT/SE2000/001179 priority patent/WO2000075659A1/en
Priority to AU54373/00A priority patent/AU5437300A/en
Publication of SE9902155L publication Critical patent/SE9902155L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to antibodies towards nucleus pulposus cells and the use thereof for manufacturing a kit for diagnosing disc herniation, as well as anti-antibody to said antibody, and its use for treating disc herniation as well as sciatica, as well as a false antibody to the antibody to nucleus pulposus cells as well as soluble antigens form nucleus pulposus cells to block such said antibodies.
SE9902155A 1999-06-09 1999-06-09 Serum antibodies SE9902155L (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9902155A SE9902155L (en) 1999-06-09 1999-06-09 Serum antibodies
PCT/SE2000/001179 WO2000075659A1 (en) 1999-06-09 2000-06-07 Antibodies to nucleus pulposus in disc herniation, diagnostic kit, medical preparations and treatment
AU54373/00A AU5437300A (en) 1999-06-09 2000-06-07 Antibodies to nucleus pulposus in disc herniation, diagnostic kit, medical preparations and treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902155A SE9902155L (en) 1999-06-09 1999-06-09 Serum antibodies

Publications (2)

Publication Number Publication Date
SE9902155D0 SE9902155D0 (en) 1999-06-09
SE9902155L true SE9902155L (en) 2000-12-10

Family

ID=20415987

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9902155A SE9902155L (en) 1999-06-09 1999-06-09 Serum antibodies

Country Status (3)

Country Link
AU (1) AU5437300A (en)
SE (1) SE9902155L (en)
WO (1) WO2000075659A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045577A2 (en) 1999-12-06 2001-06-28 Sdgi Holdings, Inc. Intervertebral disc treatment devices and methods
US20040054414A1 (en) 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
JP2006515765A (en) 2002-11-15 2006-06-08 エスディージーアイ・ホールディングス・インコーポレーテッド Collagen-based materials and methods for treating synovial joints
US8399619B2 (en) 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
US8118779B2 (en) 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
JP2019513823A (en) * 2016-04-04 2019-05-30 ゲーウー・ベンチャーズ・アーベー Methods and compositions for the treatment of intervertebral disc herniations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
DE3918082A1 (en) * 1989-06-02 1991-01-24 Max Planck Gesellschaft AGENT FOR AUTOIMMUNE DISEASES
BR9007950A (en) * 1989-12-20 1992-10-27 Brigham & Womens Hospital METHOD FOR TREATING OR PREVENTING THE MANIFESTATION OF AN AUTO-IMMUNE DISEASE IN A MAMMAL, PHARMACEUTICAL FORMULATION, METHOD FOR TREATING AN AUTO-IMMUNE DISEASE, AND METHOD FOR TREATING A MAMMAL WITH ACCIDENT OF AUTO-IMMUNE DISEASE
WO1994014070A1 (en) * 1992-12-04 1994-06-23 Shriners Hospitals For Crippled Children Immunoassay for the measurement of collagen cleavage in cartilage
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
AUPO571297A0 (en) * 1997-03-19 1997-04-10 Montech Medical Developments Pty Ltd Method for the diagnosis of rheumatoid arthritis

Also Published As

Publication number Publication date
SE9902155D0 (en) 1999-06-09
AU5437300A (en) 2000-12-28
WO2000075659A1 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
NO981745D0 (en) Monoclonal antibody BR110 and its use
DE69619493T2 (en) POLYPEPTIDE-DENDRIMER COMPLEXES
NZ337413A (en) Antibodies that bind to Prostate Stem Cell Antigen (PSCA) to treat prostate cancer.
DE69503903D1 (en) POSITIVE AND POSITIVE / NEGATIVE CELL SELECTION BROKEN BY PEPTIO RELEASE
RS50477B (en) Anti-il-12 antibodies, compositions, methods and uses
ATE239228T1 (en) AUTOMATIC IMMUNOASSAY CASSETTE
CA2406240A1 (en) Hcv anti-core monoclonal antibodies
ES2293973T3 (en) ANTIBODIES ANTI-CCR2 HUMANIZED AND METHODS OF USE OF THE SAME.
EP0420913A4 (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
WO2002082076A3 (en) Renal cell carcinoma tumor markers
WO2001049823A3 (en) Assays for detection of bacillus anthracis
GB2383331A (en) Monoclonal antibody DS6 Tumor-associated antigen CA6 and methods of use thereof
EP1579222B8 (en) Non-competitive immunoassay for small analytes
EP0847452A4 (en) Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell
PT827512E (en) SPECIFIC ANTIBODY FOR STAPHYLOCOCCUS AUREUS AND ITS UTILIZATION
CA2348026A1 (en) Antibodies against semp1, methods for their production and uses thereof
MX9401112A (en) PREPARATION OF PHOTOPROTEIN CONJUGATES AND METHODS TO USE THEM.
SE9902155D0 (en) Serum antibodies
FI922017A0 (en) IMMUNBESTAEMNINGAR OCH MONOCLONALA ANTIKROPPAR FOER PROTROMBINAKTIVERINGSPEPTIDER OCH DEGRADATIONS- PRODUKTER AV DESSA.
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
ATE282830T1 (en) IMMUNE TEST FOR HUMAN CHROMOGRANINE A (CGA), ANTIBODIES, REAGENT AND SUITABLE TEST SET
SE0002835D0 (en) Method and kit for production of monoclonal antibodies
EA200100287A1 (en) HIGH-AFFINITY ANTIBODIES
AU2001250470A1 (en) Novel antibodies specifically identifying inactive psa, and uses thereof
BR0204612A (en) Hcv Antibody Monoclonal Antibodies

Legal Events

Date Code Title Description
NAV Patent application has lapsed